摘要
本文研究总结了北医联合生物工程公司研制的GM-CSF,应用于恶性肿瘤化疗引起的白细胞减少12例,其白细胞减少时间较对照组缩短5天。对合并感染的病人有较明显的抗感染作用,降低了抗生素的作用时间。临床应用常规剂量未发生明显副作用。是肿瘤根治性化疗的抢救、保驾药品。
The present study was designed to confirm the use of GM-CSF, made by the Beijing United Biological Engineering Company, in leucocytopenia after chemotherapy in 12 patients with malignant tumor. In patients with malignant tumor the interval leucocytopenia needed shortened 5 days compared with that in control subjects. At the same time GM-CSF could be resistant to infection significantly, especially in patients with complicated infection, and the antibiotic applying time decreased. In addition, clinical experence had shown that there was no obvious side-effects in general dosage. Thus, these findings indicate that GM-CSF is a kind of essential drug in radical chemotherapy in patients with tumor.
出处
《中国肿瘤生物治疗杂志》
CAS
CSCD
1995年第3期197-200,共4页
Chinese Journal of Cancer Biotherapy
